Literature DB >> 222806

Counterimmunoelectrophoresis test for immunoglobulin M antibodies to group B coxsackievirus.

T E Minor, P B Helstrom, D B Nelson, D J D'Alessio.   

Abstract

A counterimmunoelectrophoresis test was developed for immunoglobulin M (IgM) antibodies to group B coxsackievirus (CB) types 1 through 5. The IgM precipitin line could be identified and differentiated from the IgG line by treating sera with 2-mercaptoethanol. Antigen purity was demonstrated by single precipitin lines occurring only to the homologous antigen when tested with type-specific hyperimmune rabbit sera. Serum pairs from 19 of 22 patients with documented CB type 1,3,4, and 5 infections were positive for IgM antibody to the infecting serotype, whereas 2 of 7 pairs from CB type 2 patients were positive. Heterologous IgM antibodies were present in sera from 14 fo 29 CB patients. Of the 14 patients with heterologous IgM antibodies, 12 also had greater than or equal to 4-fold rises in whole serum neutralizing antibody to heterologous serotypes. Only three control sera from 72 patients with coxsackievirus group A, echovirus, or other viral infections had IgM antibody to CB serotypes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222806      PMCID: PMC273063          DOI: 10.1128/jcm.9.4.503-506.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Gel double diffusion studies with group B and group A, type 9 Coxsackie viruses. I. The technique and reactions obtained with hyperimmune animal sera and human sera.

Authors:  N J SCHMIDT; E H LENNETTE
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

2.  Gel double diffusion studies with group B and group A, type 9 Coxsackie viruses. II. Serologic diagnosis of Coxsackie virus infections by the gel double diffusion technique.

Authors:  N J SCHMIDT; E H LENNETTE
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

3.  Counter-electrophoresis as a possible method for typing ECHO and Coxsackie B viruses.

Authors:  K M MacWilliam; K M Cook
Journal:  J Hyg (Lond)       Date:  1975-04

4.  Characterization of antibodies produced in natural and experimental coxsackievirus infections.

Authors:  N J Schmidt; E H Lennette; J Dennis
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

5.  Association of group B coxsackie viruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody.

Authors:  N J Schmidt; R L Magoffin; E H Lennette
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

6.  A six-year study of coxsackievirus B infections in heart disease.

Authors:  N R Grist; E J Bell
Journal:  J Hyg (Lond)       Date:  1974-10
  6 in total
  12 in total

1.  Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins.

Authors:  F Reigel; F Burkhardt; U Schilt
Journal:  J Hyg (Lond)       Date:  1985-10

2.  Heterotypic reactions in a radioimmunoassay for coxsackie B virus specific IgM.

Authors:  S F Pugh
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

3.  Tests for coxsackie B virus-specific IgM.

Authors:  J R Pattison
Journal:  J Hyg (Lond)       Date:  1983-06

4.  Vaccine-related poliomyelitis: serum IgM and cerebrospinal fluid antibodies.

Authors:  H Openshaw; J S Lieberman
Journal:  West J Med       Date:  1983-03

5.  Determination of serum neutralization antibodies to rabies virus by a modified counterimmunoelectrophoresis test.

Authors:  A M Díaz; D M Myers
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

6.  Comparison of serodiagnosis of group B coxsackievirus infections by an immunoglobulin M capture enzyme immunoassay versus microneutralization.

Authors:  D Chan; G W Hammond
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

7.  Human infective dose determinations for oral poliovirus type 1 vaccine in infants.

Authors:  T E Minor; C I Allen; A A Tsiatis; D B Nelson; D J D'Alessio
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

8.  Detection of enterovirus specific IgG and IgM antibodies in humans by an indirect solid phase radioimmunoassay.

Authors:  R Dörries; V ter Meulen
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  Immunoglobulin M responses to the Norwalk virus of gastroenteritis.

Authors:  G Cukor; N A Nowak; N R Blacklow
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

Review 10.  Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.

Authors:  T Chonmaitree; C D Baldwin; H L Lucia
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.